Celon Pharma is a Polish pharmaceutical company based near Warsaw that develops and manufactures medicines. It makes generic prescription drugs and also works on its own innovative treatments, including inhaled medicines delivered through its own inhaler technology and products for cancer and central nervous system conditions. The company carries out research and manufacturing at its own facilities and supplies patients and healthcare providers in Poland and in export markets.
On this site Celon Pharma SA appears as a stock on the Warsaw Stock Exchange (Poland), code CLN, with prices in Polish zloty (PLN). Our dividend records, which start in 2019, show payments in 6 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Fair price profile
Ranks #198 of 580 on the Warsaw Stock Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for Poland yet.
TrendWeak
49/100
Below its long-term averages and far from its highs.
See the numbers →
Above 200-day average-6.7%
From 52-week high-17.0%
MomentumWeak
40/100
Lagging most stocks on this exchange.
See the numbers →
3-month return-5.3%
6-month return-6.7%
12-month, skipping last month-12.8%
Stability (higher is calmer)Strong
83/100
Calmer than most: low volatility and shallow drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)26.6%
Worst drawdown, 1 year (smaller is calmer)-20.5%
LiquidityStrong
78/100
Trades actively.
See the numbers →
Avg daily value traded0.36M PLN
Zero-volume days0.0%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends3
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for Poland when fundamentals data for this market is added. All Poland stocks.
52-wk range 18.00 – 23.50Daily closes, split-adjusted
Signals
50-day average20.50
200-day average20.90
Golden/death cross (60d)Death, 14 days ago
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.69
Technical summary
Daily
Neutral
5 bullish · 4 neutral · 7 bearish
Weekly
Strongly bearish
0 bullish · 1 neutral · 11 bearish
Monthly
Strongly bearish
0 bullish · 1 neutral · 7 bearish
Moving averages (daily)
SMA 10
19.25
Bullish
EMA 10
19.36
Bullish
SMA 20
19.13
Bullish
EMA 20
19.45
Bullish
SMA 50
20.50
Bearish
EMA 50
20.00
Bearish
SMA 100
20.45
Bearish
EMA 100
20.38
Bearish
SMA 200
20.90
Bearish
EMA 200
20.83
Bearish
Oscillators (daily)
RSI (14)
48.41
Neutral
MACD (12, 26)
-0.23
Bearish
Momentum (12)
2.63
Bullish
Stochastic %K (14)
41.44
Neutral
Williams %R (14)
-58.56
Neutral
CCI (20)
46.62
Neutral
Pivot points (classic, last session)
S3
18.32
S2
18.66
S1
19.08
Pivot
19.42
R1
19.84
R2
20.18
R3
20.60
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Dividends
Paid, last 12 months
0.00 PLN
Yield on today's price
–
Frequency
None in the last year
Next ex-dividend date
Not announced
Ex-dividend date
Amount per share
0.0800
0.0900
0.2900
0.0700
0.0800
0.2400
Ex-dividend dates and amounts from EODHD. Shown as declared, before tax.
Prices are end-of-day closes in PLN. Educational only, not financial advice.
